High-Risk Pregnancy Management Indian Medical PG Practice Questions and MCQs
Practice Indian Medical PG questions for High-Risk Pregnancy Management. These multiple choice questions (MCQs) cover important concepts and help you prepare for your exams.
High-Risk Pregnancy Management Indian Medical PG Question 1: A hypertensive patient wants to conceive. Which of the following medications needs to be stopped before pregnancy?
- A. ACE inhibitors (Correct Answer)
- B. Alpha Methyl dopa
- C. Calcium Channel Blockers
- D. Labetalol
- E. Hydralazine
High-Risk Pregnancy Management Explanation: ***ACE inhibitors***
- **ACE inhibitors** are **teratogenic** and can cause **fetal kidney damage**, **oligohydramnios**, and **fetal death** if used during pregnancy.
- They should be discontinued before conception or immediately upon pregnancy confirmation, and an alternative safe antihypertensive should be initiated.
*Alpha Methyl dopa*
- **Alpha-methyldopa** is considered one of the **first-line agents** for managing **hypertension in pregnancy** due to its established safety profile.
- It reduces peripheral resistance without significantly affecting renal or uteroplacental blood flow.
*Calcium Channel Blockers*
- **Calcium channel blockers (CCBs)** like nifedipine and amlodipine are **generally considered safe** for use during pregnancy, especially dihydropyridines.
- They are often used as **second-line treatments** for managing hypertension in pregnant women.
*Labetalol*
- **Labetalol** is a **beta-blocker** that is widely used and considered **safe** for treating **hypertension in pregnancy**.
- It effectively lowers blood pressure without significant adverse effects on the fetus.
*Hydralazine*
- **Hydralazine** is a direct vasodilator that is **safe** for use in pregnancy and is commonly used for **acute management** of severe hypertension in pregnant women.
- It has a long history of safe use during pregnancy without teratogenic effects.
High-Risk Pregnancy Management Indian Medical PG Question 2: The following cost-effective investigations are routinely recommended in the screening of antenatal mothers, EXCEPT:
- A. Blood sugar levels for GDM
- B. VDRL for syphilis
- C. Urine analysis for bacteriuria
- D. Echocardiography for cardiac disease (Correct Answer)
High-Risk Pregnancy Management Explanation: ***Echocardiography for cardiac disease***
- **Echocardiography** is not a *routinely recommended* screening investigation for all antenatal mothers due to its cost and the relatively low prevalence of significant congenital heart disease requiring universal screening.
- It is typically performed only if there are **specific risk factors** or suspicious findings suggesting cardiac pathology.
*Blood sugar levels for GDM*
- Screening for **gestational diabetes mellitus (GDM)** with blood sugar levels (e.g., glucose challenge test) is routinely recommended due to the potential maternal and fetal complications if untreated.
- GDM is a common condition that can be effectively managed with early diagnosis, making screening a **cost-effective** preventive measure.
*VDRL for syphilis*
- Screening for **syphilis** using tests like VDRL (Venereal Disease Research Laboratory) is a standard and *routinely recommended* antenatal investigation.
- Early detection and treatment of syphilis in pregnant women prevent serious adverse outcomes such as **congenital syphilis**, which can cause severe fetal morbidity and mortality.
*Urine analysis for bacteriuria*
- **Urine analysis** for **asymptomatic bacteriuria** is routinely recommended during pregnancy because untreated bacteriuria can lead to pyelonephritis, preterm labor, and low birth weight.
- It is a simple, **cost-effective** test with significant benefits for maternal and fetal health.
High-Risk Pregnancy Management Indian Medical PG Question 3: What is the management of eclampsia at 34 weeks of pregnancy?
- A. Continue convulsions and wait for 37 weeks to complete.
- B. Wait for spontaneous labor.
- C. Continue blood pressure management.
- D. Administer antihypertensives, anticonvulsants, and consider termination of pregnancy. (Correct Answer)
High-Risk Pregnancy Management Explanation: **Administer antihypertensives, anticonvulsants, and consider termination of pregnancy.**
- In eclampsia, emergent management includes immediate administration of **magnesium sulfate** as an anticonvulsant and **antihypertensives** (e.g., labetalol, hydralazine, nifedipine) to control blood pressure.
- Given the gestational age of 34 weeks and the occurrence of eclampsia, **delivery of the fetus** is often indicated to resolve the maternal condition, regardless of fetal lung maturity.
*Continue convulsions and wait for 37 weeks to complete.*
- Allowing **convulsions to continue** is extremely dangerous for both mother and fetus, increasing risks of aspiration, trauma, hypoxemia, and placental abruption.
- Eclampsia is a severe complication of pregnancy that necessitates immediate intervention and **should not be passively observed** until full term.
*Wait for spontaneous labor.*
- **Delaying delivery** while waiting for spontaneous labor in eclampsia significantly prolongs the mother's exposure to the severe complications of the condition.
- Eclampsia is an ** obstetric emergency** where prompt delivery, often via induction or C-section, is the definitive cure.
*Continue blood pressure management.*
- While **blood pressure management** is a crucial component of eclampsia treatment, it is insufficient on its own.
- Eclampsia specifically involves **seizures**, which require anticonvulsant therapy (magnesium sulfate) in addition to antihypertensives, and the ultimate treatment is delivery.
High-Risk Pregnancy Management Indian Medical PG Question 4: Which is not a risk factor for gestational hypertension
- A. Primigravida
- B. Factor V Leiden mutation
- C. Smoking (Correct Answer)
- D. Low maternal age
High-Risk Pregnancy Management Explanation: ***Smoking***
- **Smoking** paradoxically shows a *protective effect* against gestational hypertension and preeclampsia, making it the correct answer as it is NOT a risk factor for gestational hypertension.
- This well-documented phenomenon may be related to smoking's vasodilatory effects and reduced production of anti-angiogenic factors.
- However, smoking carries numerous other serious risks including **intrauterine growth restriction (IUGR)**, **placental abruption**, **preterm birth**, and **perinatal mortality**.
*Primigravida*
- **Primigravida** (first pregnancy) is a well-established risk factor for gestational hypertension and preeclampsia.
- First-time exposure to paternal antigens and incomplete immune tolerance may contribute to this increased risk.
- The risk decreases in subsequent pregnancies with the same partner.
*Factor V Leiden mutation*
- The **Factor V Leiden mutation** is the most common inherited thrombophilia and significantly increases the risk of gestational hypertension and preeclampsia.
- This mutation causes resistance to activated protein C, leading to a hypercoagulable state that can impair placental perfusion.
- Associated with increased risk of venous thromboembolism during pregnancy.
*Low maternal age*
- **Low maternal age** (adolescent pregnancy, <20 years) is actually a recognized *risk factor* for gestational hypertension.
- Young mothers may have incomplete physical and cardiovascular maturity to handle pregnancy-related physiological changes.
- Adolescent pregnancies are associated with higher rates of hypertensive disorders of pregnancy.
High-Risk Pregnancy Management Indian Medical PG Question 5: Placenta grade 3, 35+3 weeks pregnancy, and absent end diastolic flow Doppler; next management is:
- A. Monitor
- B. Terminate after 37 weeks
- C. Dexamethasone and terminate after 48 hours (Correct Answer)
- D. Consult pediatrician and plan immediate delivery
High-Risk Pregnancy Management Explanation: ***Dexamethasone and terminate after 48 hours***
- Absent end diastolic flow (AEDF) at 35+3 weeks indicates **severe uteroplacental insufficiency** and significant fetal compromise, requiring intervention.
- Administering **dexamethasone** (corticosteroids) for 48 hours helps to accelerate **fetal lung maturity** before delivery, reducing the risk of respiratory distress syndrome.
*Monitor*
- Simply monitoring is an inappropriate and potentially harmful management strategy given the presence of **absent end diastolic flow**, which reflects **critical fetal hypoxia**.
- Delaying intervention in cases of AEDF significantly increases the risk of **fetal demise** and severe morbidity.
*Terminate after 37 weeks*
- Waiting until 37 weeks is too long. **Absent end diastolic flow** at 35+3 weeks significantly increases the risk of **fetal compromise** and death if delivery is delayed.
- The goal is to balance the risks of prematurity with the risks of continued intrauterine compromise.
*Consult pediatrician and plan immediate delivery*
- While immediate delivery might be considered in some scenarios of fetal distress, delivering without prior **corticosteroid administration** (dexamethasone) at 35+3 weeks would increase the risk of **neonatal respiratory distress syndrome**.
- The 48-hour window allows for **fetal lung maturation** while still addressing the urgent need for delivery due to AEDF.
High-Risk Pregnancy Management Indian Medical PG Question 6: Which of the following statements about gestational diabetes mellitus (GDM) is true?
- A. It is always associated with a previous history of IUGR.
- B. There is no recurrence of GDM in future pregnancies.
- C. There is no risk of developing overt diabetes in the future.
- D. Gestational diabetes mellitus is first recognized during pregnancy. (Correct Answer)
High-Risk Pregnancy Management Explanation: ***Gestational diabetes mellitus is first recognized during pregnancy.***
- GDM is defined as **glucose intolerance** that is first recognized or diagnosed during pregnancy, regardless of whether it requires insulin or persists after pregnancy.
- This definition distinguishes it from **pre-existing type 1 or type 2 diabetes** diagnosed before conception.
*It is always associated with a previous history of IUGR.*
- GDM is primarily associated with an increased risk of **macrosomia** (large-for-gestational-age babies) due to high maternal glucose levels stimulating fetal insulin production and growth.
- While other pregnancy complications can occur, **intrauterine growth restriction (IUGR)** is not a typical or consistent association with GDM.
*There is no recurrence of GDM in future pregnancies.*
- Women who have had GDM in one pregnancy have a **significantly increased risk** (30-50%) of developing it again in subsequent pregnancies.
- This recurrence risk highlights the underlying predisposition to glucose intolerance.
*There is no risk of developing overt diabetes in the future.*
- A history of GDM is a strong predictor for developing **type 2 diabetes** later in life, with up to 50% of women developing it within 5-10 years post-delivery.
- It also carries a small increased risk of developing **type 1 diabetes** in some individuals.
High-Risk Pregnancy Management Indian Medical PG Question 7: What maternal condition is commonly associated with congenital heart defects in the fetus?
- A. ACE inhibitor
- B. GDM
- C. Pregestational DM (Correct Answer)
- D. Valproate
High-Risk Pregnancy Management Explanation: ***Pregestational DM***
- **Pre-existing diabetes** in the mother is a significant risk factor for various **congenital anomalies**, including **congenital heart defects**, due to suboptimal glycemic control during early embryogenesis.
- Poorly controlled **maternal hyperglycemia** leads to increased oxidative stress and altered cellular metabolism in the developing fetus, impacting cardiovascular development.
*ACE inhibitor*
- **ACE inhibitors** are teratogenic, primarily causing **renal dysfunction** (e.g., renal tubular dysplasia, oligohydramnios, anuria) and **fetal growth restriction**, especially when used in the second and third trimesters.
- While they can have adverse fetal effects, their association with **congenital heart defects** is less pronounced compared to other teratogenic exposures.
*GDM*
- **Gestational diabetes mellitus (GDM)** typically develops in the second or third trimester when major organogenesis is complete, making its association with **structural congenital anomalies**, including heart defects, significantly lower than pregestational diabetes.
- GDM is more commonly associated with fetal **macrosomia**, **hypoglycemia**, and respiratory distress syndrome at birth.
*Valproate*
- **Valproate** is a known teratogen associated with a specific pattern of anomalies, most notably **neural tube defects** (e.g., spina bifida), and facial dysmorphisms.
- While it can be associated with an increased risk of some congenital heart defects, its primary and most significant fetal risk is **neural tube defects**.
High-Risk Pregnancy Management Indian Medical PG Question 8: As per the Government of India guidelines, the daily dose of elemental iron recommended for prophylaxis during pregnancy is
- A. 150 mg/day for 100 days
- B. 200 mg/day for 100 days
- C. 100 mg/day for 100 days (Correct Answer)
- D. 50 mg/day for 100 days
High-Risk Pregnancy Management Explanation: ***100 mg/day for 100 days***
- As per the **Government of India guidelines**, the recommended daily dose of **elemental iron** for prophylaxis during pregnancy is 100 mg/day.
- This dose is typically continued for at least **100 days** to ensure adequate iron stores and prevent iron deficiency anemia.
*150 mg/day for 100 days*
- This dose exceeds the **recommended daily prophylactic** amount of elemental iron specified by Indian government guidelines.
- While higher doses may be used for **therapeutic treatment** of existing iron deficiency anemia, it is not the standard for prophylaxis.
*200 mg/day for 100 days*
- This amount is significantly higher than the standard **prophylactic recommendation** for elemental iron during pregnancy in India.
- Such a high dose would typically only be prescribed for **treating severe anemia**, not for routine prevention.
*50 mg/day for 100 days*
- This dose is lower than the **recommended daily amount** for effective iron prophylaxis according to the Government of India guidelines.
- Such a dose might be **insufficient** to maintain adequate iron levels and prevent anemia during pregnancy.
High-Risk Pregnancy Management Indian Medical PG Question 9: Calculate the maternal mortality ratio (MMR) for the year 2023, given the following data:
- Total live births: 4,000
- Women who died: 6 (1 due to a road traffic accident (RTA), 1 due to sepsis, 1 due to obstructed labor, 1 due to eclampsia, 1 due to ectopic pregnancy, and 1 due to a snake bite)
- A. 75 per 100,000 live births
- B. 150 per 100,000 live births
- C. 100 per 100,000 live births (Correct Answer)
- D. 125 per 100,000 live births
High-Risk Pregnancy Management Explanation: ***Correct: 100 per 100,000 live births***
- The **maternal mortality ratio (MMR)** includes deaths directly or indirectly due to pregnancy, childbirth, or within 42 days of termination of pregnancy, **excluding accidental or incidental causes**.
- In this scenario, **4 maternal deaths** are identified: sepsis (direct), obstructed labor (direct), eclampsia (direct), and ectopic pregnancy (direct).
- **Excluded deaths**: RTA and snake bite are **incidental/accidental deaths** not related to pregnancy complications.
- **Calculation**: MMR = (4 / 4,000) × 100,000 = **100 per 100,000 live births**
*Incorrect: 75 per 100,000 live births*
- This would incorrectly count only **3 maternal deaths** instead of 4, suggesting underestimation or exclusion of a valid maternal death (e.g., ectopic pregnancy).
- Represents a **miscalculation** that underestimates maternal mortality burden.
*Incorrect: 150 per 100,000 live births*
- This would incorrectly include **6 deaths** (all deaths including RTA and snake bite), failing to exclude incidental causes.
- Including **non-maternal accidental deaths** inflates MMR and misrepresents actual maternal health outcomes.
*Incorrect: 125 per 100,000 live births*
- This would incorrectly count **5 deaths**, suggesting inclusion of one incidental death (either RTA or snake bite).
- Fails to properly identify and exclude **both incidental deaths**, leading to an overestimated ratio.
High-Risk Pregnancy Management Indian Medical PG Question 10: Consider the following statements:
Statement-I: While calculating the number of expected pregnancies per year in an area, a correction factor (usually 10%) is added to the expected number of live births in the year in the area.
Statement-II: All the pregnancies in the area may not be registered by the health worker in the area. Which one of the following is correct in respect of the above statements?
- A. Statement-II is incorrect but Statement-I is correct.
- B. Statement-I is correct but Statement-II is incorrect.
- C. Statement-I and Statement-II are independently correct, and Statement-II is a correct explanation for Statement-I.
- D. Statement-I and Statement-II are independently correct, but Statement-II is not a correct explanation for Statement-I. (Correct Answer)
High-Risk Pregnancy Management Explanation: ***Statement-I and Statement-II are independently correct, but Statement-II is not a correct explanation for Statement-I.***
- Statement-I is correct because a **10% correction factor** is added to expected live births to calculate expected pregnancies in an area.
- The **primary reason** for this correction factor is to account for **pregnancy wastage** (spontaneous abortions, induced abortions, stillbirths) that do not result in live births.
- Statement-II is also correct as **under-registration of pregnancies** is a real challenge in health surveillance systems.
- However, Statement-II does **NOT correctly explain** Statement-I because the correction factor is primarily meant to account for **pregnancy outcomes that don't lead to live births**, not for under-registration issues.
- Under-registration would require a different type of adjustment in the surveillance system, not the correction factor applied to convert live births to expected pregnancies.
*Statement-I and Statement-II are independently correct, and Statement-II is a correct explanation for Statement-I.*
- While both statements are correct, Statement-II is **not the correct explanation** for Statement-I.
- The correction factor exists primarily to account for **pregnancy wastage** (miscarriages, abortions, stillbirths), not for under-registration of pregnancies.
- Under-registration is a separate data quality issue that affects the accuracy of all health statistics.
*Statement-II is incorrect but Statement-I is correct.*
- Statement-II is **correct** as incomplete registration of pregnancies is a well-documented challenge in community health programs.
- Therefore, this option is incorrect.
*Statement-I is correct but Statement-II is incorrect.*
- Statement-II is **correct** as under-registration of pregnancies does occur in health surveillance systems.
- Therefore, this option is incorrect.
More High-Risk Pregnancy Management Indian Medical PG questions available in the OnCourse app. Practice MCQs, flashcards, and get detailed explanations.
